Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low Post-Treatment Recurrence After a Shortened All-oral Regimen for Pulmonary Rifampicin- or Multidrug-Resistant Tuberculosis in Individuals without Prior Second-Line Drug Exposure in Kazakhstan.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Post-release tuberculosis risk among formerly incarcerated populations in Lima Peru.

Nature communications·2026
Same author

Comparison of three linezolid management strategies for peripheral neuropathy in multidrug- or rifampicin-resistant tuberculosis treatment: a target trial emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Interventions to reduce the impact of post-tuberculosis lung disease: a scoping review of the literature.

BMC pulmonary medicine·2026
Same author

endTB-Q trial: a caveat on confounding by baseline drug resistance - Authors' reply.

The Lancet. Respiratory medicine·2026
Same author

Quantifying within-household tuberculosis transmission: a systematic review and prospective cohort study.

International journal of epidemiology·2026

Related Experiment Video

Updated: May 16, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence.

Molly F Franke1, Sasha C Appleton, Carole D Mitnick

  • 1Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|December 11, 2012
PubMed
Summary
This summary is machine-generated.

An aggressive multidrug-resistant tuberculosis (MDR-TB) regimen lasting over 18 months after sputum conversion significantly lowers the risk of recurrent tuberculosis. Diabetes mellitus increases this risk, necessitating careful patient management.

Related Experiment Videos

Last Updated: May 16, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Area of Science:

  • Infectious Diseases
  • Public Health
  • Clinical Medicine

Background:

  • Recurrence of tuberculosis after treatment for multidrug-resistant tuberculosis (MDR-TB) affects up to 29% of patients.
  • Understanding factors influencing MDR-TB recurrence is crucial for optimizing treatment strategies.

Purpose of the Study:

  • To investigate the association between an aggressive MDR-TB treatment regimen and the rate of recurrent tuberculosis post-cure.
  • To identify patient-specific factors, such as diabetes mellitus, associated with MDR-TB recurrence.

Main Methods:

  • A retrospective cohort study was conducted involving adults treated for MDR-TB in Peru.
  • Multivariable Cox proportional hazards regression analysis was employed to assess treatment duration and recurrence risk.

Main Results:

  • Treatment with an aggressive MDR-TB regimen for ≥18 months post-sputum conversion was linked to a reduced risk of recurrence (HR, 0.40; P = .04).
  • A baseline diagnosis of diabetes mellitus was a significant predictor of recurrent tuberculosis (HR, 10.47; P = .004).

Conclusions:

  • Extended aggressive MDR-TB therapy (≥18 months) following sputum conversion is associated with lower recurrence rates.
  • Ensuring access to effective MDR-TB regimens and developing new compounds are vital for reducing recurrence.
  • Close monitoring and management of patients with diabetes mellitus are recommended to prevent recurrent tuberculosis.